Trial Search Results

Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)

The primary purpose of this study is to compare standard treatments to reduced intensity allogeneic transplants for the treatment of myelodysplastic syndromes (MDS).

Stanford is currently not accepting patients for this trial.

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Physician Referrals
650-723-0822
Not Recruiting